These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 9244196)

  • 21. Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial.
    Peters S; Götting B; Trümmel M; Rust H; Brattström A
    J Invasive Cardiol; 2001 Feb; 13(2):93-7. PubMed ID: 11176015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous femoral artery angioplasty with stent-in-stent technique and tirofiban administration.
    Ambrosini V; Battaglia S; Cioppa A; Lo Muzio L; Salemme L; Sorropago G; Tesoria T; Rubino P
    J Invasive Cardiol; 2002 Oct; 14(10):619-23. PubMed ID: 12368517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of pre-stent plaque debulking for chronic coronary total occlusions on restenosis reduction.
    Tsuchikane E; Otsuji S; Awata N; Azuma J; Nakaoka Y; Uesugi H; Kobayashi T; Sakurai M; Kobayashi T
    J Invasive Cardiol; 2001 Aug; 13(8):584-9. PubMed ID: 11481507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on radiation for restenosis.
    French MH; Faxon DP
    Rev Cardiovasc Med; 2002; 3(1):1-6. PubMed ID: 12439348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of statins on six-month survival and clinical restenosis frequency after coronary stent deployment.
    Bunch TJ; Muhlestein JB; Anderson JL; Horne BD; Bair TL; Jackson JD; Li Q; Lappé DL
    Am J Cardiol; 2002 Aug; 90(3):299-302. PubMed ID: 12127616
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta-particle-emitting stents radiate enthusiasm in the search for effective prevention of restenosis.
    van der Giessen WJ; Serruys PW
    Circulation; 1996 Nov; 94(10):2358-60. PubMed ID: 8921772
    [No Abstract]   [Full Text] [Related]  

  • 27. Novel antithrombotic therapy.
    Rodgers GM
    West J Med; 1993 Dec; 159(6):670-4. PubMed ID: 8128675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Possible antithrombotic effects of nitrates].
    Kornowski R; Battler A
    Harefuah; 1994 May; 126(10):590-3. PubMed ID: 8034249
    [No Abstract]   [Full Text] [Related]  

  • 29. Local drug delivery for the prevention of restenosis. Fact, fancy, and future.
    Lincoff AM; Topol EJ; Ellis SG
    Circulation; 1994 Oct; 90(4):2070-84. PubMed ID: 7923695
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of Different Antithrombotic Regimens to Prevent Postoperative Restenosis in Patients With Lower Extremity Arteriosclerosis.
    Gao Z; Qin Y; Yu T; Wang W; Zhu CY; Qiao T; Li XQ; Da L; Ran F
    Am J Ther; 2021 Feb; 28(4):e517-e520. PubMed ID: 33443871
    [No Abstract]   [Full Text] [Related]  

  • 31. [Oxygen multi-stage therapy].
    Nolte D
    Dtsch Med Wochenschr; 1990 Mar; 115(10):395. PubMed ID: 2311513
    [No Abstract]   [Full Text] [Related]  

  • 32. Antithrombotic therapy for cancer.
    Zacharski LR
    Ann Intern Med; 1982 Feb; 96(2):258. PubMed ID: 7059085
    [No Abstract]   [Full Text] [Related]  

  • 33. Protein-binding oligonucleotides: the next frontier in antithrombotic therapy.
    Becker RC
    J Thromb Thrombolysis; 2004 Apr; 17(2):157-9. PubMed ID: 15306753
    [No Abstract]   [Full Text] [Related]  

  • 34. Intensification of antithrombotic therapy for chronic atherosclerosis.
    Pope MK; Ghanima W; Atar D
    Tidsskr Nor Laegeforen; 2020 Jun; 140(10):. PubMed ID: 32602309
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic risk factors and restenosis after percutaneous coronary interventions.
    Kastrati A; Dirschinger J; Schömig A
    Herz; 2000 Feb; 25(1):34-46. PubMed ID: 10713908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stent restenosis: can effective antithrombotic therapy be protective?
    Willerson JT
    Circulation; 1997 Jul; 96(2):383-5. PubMed ID: 9244196
    [No Abstract]   [Full Text] [Related]  

  • 37. Contemporary antithrombotic strategies in patients undergoing coronary stent implantation.
    Bartorelli AL; Trabattoni D
    Minerva Cardioangiol; 2002 Oct; 50(5):517-30. PubMed ID: 12384634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolution of antithrombotic therapy in coronary stenting.
    Schatz RA
    Am Heart J; 1997 Nov; 134(5 Pt 2):S78-80. PubMed ID: 9396638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.
    Kastrati A; Schühlen H; Hausleiter J; Walter H; Zitzmann-Roth E; Hadamitzky M; Elezi S; Ulm K; Dirschinger J; Neumann FJ; Schömig A
    Circulation; 1997 Jul; 96(2):462-7. PubMed ID: 9244213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Triplex antithrombotic therapy after coronary-stent implantation (that is absent from recommendation)].
    Lengyel M
    Orv Hetil; 2005 Sep; 146(37):1937-8. PubMed ID: 16255379
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.